NCT00771433View on ClinicalTrials.gov

G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

May 31, 2011

Conditions
Breast CancerChemotherapeutic Agent ToxicityNeutropenia
Interventions
BIOLOGICAL

filgrastim

Given subcutaneously

Trial Locations (1)

14076

Centre Regional Francois Baclesse, Caen

All Listed Sponsors
lead

Centre Francois Baclesse

OTHER

NCT00771433 - G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer | Biotech Hunter | Biotech Hunter